ABSTRACT
Reduced function of the N-methyl-d-aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. The NMDAR contains a glycine binding site in its NR1 subunit that may be a useful target for the treatment of schizophrenia. In this study, we assessed the therapeutic potential of long-term increases in the brain levels of the endogenous NMDAR glycine site agonist D-serine, through the genetic inactivation of its catabolic enzyme D-amino acid oxidase (DAO) in mice. The effects of eliminating DAO function were investigated in mice that display schizophrenia-related behavioral deficits due to a mutation (Grin 1(D481N)) in the NR1 subunit that results in a reduction in NMDAR glycine affinity. Grin 1(D481N) mice show deficits in sociability, prolonged latent inhibition, enhanced startle reactivity and impaired spatial memory. The hypofunctional Dao 1(G181R) mutation elevated brain levels of D-serine, but alone it did not affect performance in the behavioral measures. Compared to animals with only the Grin 1(D481N) mutation, mice with both the Dao1(G181R) and Grin 1(D481N) mutations displayed an improvement in social approach and spatial memory retention, as well as a reversal of abnormally persistent latent inhibition and a partial normalization of startle responses. Thus, an increased level of D-serine resulting from decreased catalysis corrected the performance of mice with deficient NMDAR glycine site activation in behavioral tasks relevant to the negative and cognitive symptoms of schizophrenia. Diminished DAO activity and elevations in D-serine may serve as an effective therapeutic intervention for the treatment of psychiatric symptoms.
Subject(s)
D-Amino-Acid Oxidase/deficiency , Phenotype , Schizophrenia/enzymology , Schizophrenia/genetics , Animals , Arginine , Asparagine , Aspartic Acid , Behavior, Animal , Binding Sites , Carrier Proteins/genetics , D-Amino-Acid Oxidase/genetics , Female , Glycine/metabolism , Male , Mice , Mutation , Nerve Tissue Proteins/genetics , Nervous System/physiopathology , Receptors, N-Methyl-D-Aspartate/metabolism , Schizophrenia/physiopathology , Schizophrenic Psychology , Serine/metabolism , Social Behavior , StereoisomerismABSTRACT
Binding of the 48 amino acid polypeptide of the mature heat-stable Escherichia coli enterotoxin b (STb) to the functional receptor sulfatide (SFT) constitutes the first step in inducing secretory diarrhoea in the intestinal lumen of animals. The NMR structure of this toxin dictated the choice of amino acids for site-directed mutagenesis to delineate the binding site of STb to SFT. Amino acids facing the solvent either in the loop or the hydrophobic alpha-helix were selected. Seventeen site-specific mutants of STb toxin were produced and purified by high-pressure liquid chromatography. Enterotoxicity of the 17 mutants was determined using a rat loop assay and binding was evaluated using a microtitre plate binding assay. Both hydrophobic and electrostatic interactions are important for STb attachment. When mutations (F37K, I41S and M42S) were introduced into the hydrophobic alpha-helix to lessen hydrophobicity, binding activity and enterotoxicity decreased by more than sixfold. The loop defined by C21 and C36 also made specific contributions. Mutants generated at basic residues (K22, K23 and R29) within this region exhibited both reduced binding activities and reduced toxic activities. For all STb mutants constructed and analysed, when binding to SFT was reduced, a reduction in toxicity equivalent or greater was noted, indicating that binding to SFT is a step that precedes the toxic effect observed for STb toxin. Significantly, when the negatively charged D30 was substituted for either alanine or valine, the binding to SFT was about twice that of native STb, whereas the enterotoxicity was reduced by half.
Subject(s)
Bacterial Toxins/metabolism , Enterotoxins/metabolism , Escherichia coli/metabolism , Guanylate Cyclase/metabolism , Receptors, Cell Surface/metabolism , Receptors, Peptide/metabolism , Amino Acid Sequence , Animals , Bacterial Toxins/genetics , Bacterial Toxins/isolation & purification , Bacterial Toxins/toxicity , Binding Sites , Circular Dichroism , Enterotoxins/genetics , Enterotoxins/isolation & purification , Enterotoxins/toxicity , Escherichia coli/pathogenicity , Escherichia coli Proteins , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Male , Molecular Sequence Data , Mutagenesis, Site-Directed , Protein Conformation , Rats , Rats, Sprague-Dawley , Receptors, Enterotoxin , Receptors, Guanylate Cyclase-Coupled , Structure-Activity Relationship , Water/chemistryABSTRACT
Using a chemical cross-linker and gel electrophoresis or a dot blot overlay assay, we studied protein-protein interaction of STb toxin, a 48-residue amphiphilic polypeptide causing intestinal disorders. For the first time, we report on the oligomerization property of STb. This enterotoxin forms hexamers and heptamers in a temperature-independent fashion in presence or absence of its receptor (sulfatide) anchored in a 50-nm liposome or as a free molecule. Full STb structure integrity is necessary for its oligomerization as this process is not observed under reducing conditions in the presence of beta-mercaptoethanol. STb treatment with tetramethylurea (TMU) and different detergents prevented oligomerization. Site-directed mutagenesis decreasing overall STb hydrophobicity in the hydrophobic alpha-helix resulted in the incapacity to form oligomers. Taken together, these data suggest that the C-terminal hydrophobic alpha-helix corresponds to the domain of STb-STb inter-binding where hydrophobic interaction is involved.
